Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-06-21 Sale |
2021-06-23 4:09 pm |
Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer |
6,200 | $5.1585 | $31,983 | 165,735 (Direct) |
View |
2021-06-07 Sale |
2021-06-08 5:32 pm |
Adamas Pharmaceuticals Inc | ADMS | DEMSKI MARTHA J Director |
2,000 | $5.17 | $10,340 | 21,000 (Indirect Direct) |
View |
2021-03-22 Sale |
2021-03-23 6:06 pm |
Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer |
1,051 | $5.5 | $5,781 | 169,435 (Direct) |
View |
2021-03-22 Sale |
2021-03-23 6:02 pm |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
2,422 | $5.48 | $13,273 | 145,017 (Direct) |
View |
2021-03-11 Purchase |
2021-03-15 3:24 pm |
Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director |
5,975 | $5.06 | $30,233 | 15,975 (Direct) |
View |
2021-02-01 Sale |
2021-02-01 9:39 pm |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
3,821 | $6.36 | $24,302 | 72,439 (Direct) |
View |
2021-02-01 Sale |
2021-02-01 9:37 pm |
Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer |
4,514 | $6.39 | $28,844 | 95,486 (Direct) |
View |
2021-01-20 Sale |
2021-01-22 5:29 pm |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
2,630 | $4.41 | $11,598 | 76,260 (Direct) |
View |
2020-11-02 Sale |
2020-11-02 4:44 pm |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
2,050 | $3.21 | $6,581 | 78,890 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-11-24 Equity Swap |
2021-11-24 4:11 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | BIGHAM MICHAEL Director |
10,000 | $0 | 0 (Direct) |
View |
2021-11-24 Equity Swap |
2021-11-24 4:11 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director |
117,781 | $0 | 0 (Direct) |
View |
2021-11-24 Option Award |
2021-11-24 4:10 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer |
75,000 | $0 | 0 (Direct) |
View |
2021-11-24 Equity Swap |
2021-11-24 4:10 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer |
600,000 | $0 | 0 (Direct) |
View |
2021-11-24 Option Award |
2021-11-24 4:10 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
18,750 | $0 | 0 (Direct) |
View |
2021-11-24 Equity Swap |
2021-11-24 4:10 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
163,767 | $0 | 0 (Direct) |
View |
2021-11-24 Equity Swap |
2021-11-24 4:09 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Ericson William W. Director 10% Owner |
4,629,796 | $0 | 0 (Direct) |
View |
2021-11-24 Option Award |
2021-11-24 4:09 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer |
18,750 | $0 | 0 (Direct) |
View |
2021-11-24 Equity Swap |
2021-11-24 4:09 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer |
186,786 | $0 | 0 (Direct) |
View |
2021-11-24 Equity Swap |
2021-11-24 4:09 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director |
20,975 | $0 | 0 (Direct) |
View |
2021-11-24 Equity Swap |
2021-11-24 4:08 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | RICHO ANNA Director |
25,000 | $0 | 0 (Direct) |
View |
2021-11-24 Equity Swap |
2021-11-24 4:08 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | DEMSKI MARTHA J Director |
21,000 | $0 | 0 (Indirect) |
View |
2021-11-24 Equity Swap |
2021-11-24 4:07 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director |
202,000 | $0 | 0 (Direct) |
View |
2021-06-02 Option Award |
2021-06-04 4:17 pm |
2022-06-02 2031-06-01 |
Adamas Pharmaceuticals Inc | ADMS | RICHO ANNA Director |
15,000 | $0 | 35,000 (Direct) |
View |
2021-06-02 Option Award |
2021-06-04 4:16 pm |
2022-06-02 2031-06-01 |
Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director |
15,000 | $0 | 30,975 (Direct) |
View |
2021-06-02 Option Award |
2021-06-04 4:15 pm |
2022-06-02 2031-06-01 |
Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director |
15,000 | $0 | 127,781 (Direct) |
View |
2021-06-02 Option Award |
2021-06-04 4:15 pm |
2022-06-02 2031-06-01 |
Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director |
15,000 | $0 | 212,000 (Direct) |
View |
2021-06-02 Option Award |
2021-06-04 4:14 pm |
2022-06-02 2031-06-01 |
Adamas Pharmaceuticals Inc | ADMS | Ericson William W. Director 10% Owner |
15,000 | $0 | 4,639,796 (Direct) |
View |
2021-06-02 Option Award |
2021-06-04 4:13 pm |
2022-06-02 2031-06-01 |
Adamas Pharmaceuticals Inc | ADMS | Dier Mardi Director |
15,000 | $0 | 20,000 (Direct) |
View |
2021-06-02 Option Award |
2021-06-04 4:13 pm |
2022-06-02 2031-06-01 |
Adamas Pharmaceuticals Inc | ADMS | DEMSKI MARTHA J Director |
15,000 | $0 | 33,000 (Direct) |
View |
2021-06-02 Option Award |
2021-06-04 4:12 pm |
2022-06-02 2031-06-01 |
Adamas Pharmaceuticals Inc | ADMS | BIGHAM MICHAEL Director |
15,000 | $0 | 20,000 (Direct) |
View |
2021-03-12 Exercise |
2021-03-16 5:23 pm |
N/A 2021-11-15 |
Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director |
48,000 | $0 | 112,781 (Direct) |
View |
2021-03-12 Exercise |
2021-03-16 5:23 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director |
48,000 | $0.665 | 112,781 (Direct) |
View |
2021-03-12 Exercise |
2021-03-16 5:20 pm |
N/A 2021-11-15 |
Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director |
192,000 | $0 | 197,000 (Direct) |
View |
2021-03-12 Exercise |
2021-03-16 5:20 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director |
192,000 | $0.665 | 197,000 (Direct) |
View |
2021-03-02 Option Award |
2021-03-03 5:01 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer |
300,000 | $0 | 525,000 (Direct) |
View |
2021-03-02 Option Award |
2021-03-03 4:59 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer |
75,000 | $0 | 170,486 (Direct) |
View |
2021-03-02 Option Award |
2021-03-03 4:56 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
75,000 | $0 | 147,439 (Direct) |
View |
2020-11-22 Option Award |
2020-11-24 5:57 pm |
N/A 2030-11-21 |
Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2020-11-24 5:52 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director |
0 | $0 | 0 (Direct) |
View |
2020-08-29 Option Award |
2020-09-01 4:44 pm |
N/A 2030-08-28 |
Adamas Pharmaceuticals Inc | ADMS | RICHO ANNA Director |
30,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2020-09-01 4:42 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | RICHO ANNA Director |
0 | $0 | 10,000 (Direct) |
View |
2020-06-03 Option Award |
2020-06-05 7:42 pm |
N/A 2030-06-02 |
Adamas Pharmaceuticals Inc | ADMS | Ericson William W. Director 10% Owner |
15,000 | $0 | 4,634,796 (Direct) |
View |
2020-06-03 Option Award |
2020-06-05 6:45 pm |
N/A 2030-06-02 |
Adamas Pharmaceuticals Inc | ADMS | LIEBERBURG IVAN M Director |
15,000 | $0 | 79,000 (Direct) |
View |
2020-06-03 Option Award |
2020-06-05 6:14 pm |
N/A 2030-06-02 |
Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director |
15,000 | $0 | 74,781 (Direct) |
View |
2020-06-03 Option Award |
2020-06-05 6:12 pm |
N/A 2030-06-02 |
Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director |
15,000 | $0 | 15,000 (Direct) |
View |